InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial

October 6, 2026 — Quantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement (“SUA”) with the clinical research business of Thermo Fisher Scientific to implement its Phase 2 clinical trial of Lucid-21-302 (“Lucid-MS”) for multiple sclerosis (“MS”). The agreement initiates formal study start-up activities following FDA clearance to proceed with the trial.


Ecommerce is Expected to Record 5% Growth in Europe

October 6, 2026 — Europe’s online shopping market is still growing, but not as fast as before. According to the latest European E-commerce Report 2026, ecommerce sales across the continent are forecast to rise by 5% in 2026, reaching €961 billion ($1.


MiningNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML; FSE: HK6) Authorizes $20 Million Share Repurchase Program

October 6, 2026 — Greenland Mines (NASDAQ: GRML; FSE: HK6) announced that its board of directors authorized a $20 million share repurchase program as part of an updated capital allocation strategy focused on advancing its core mineral projects, maintaining liquidity and maximizing long-term shareholder value. Following its recent raise of more than $59 million, the company said it is positioned to fund planned work at Sarfartoq and Skaergaard through targeted 2027 milestones while retaining flexibility to repurchase shares.


Amazon Signs Another PPA to Expand its UK Renewables Investment

October 6, 2026 — Amazon has signed a new power agreement backing a wind farm planned for Shetland, adding to a UK renewable portfolio that now runs past 50 separate projects. The deal with Norwegian energy firm Statkraft covers the Mossy Hill site, which is on track to come online in late 2030, and gives the developer the backing needed to push the project toward actual construction.


TechMediaBreaks – Rezolve Ai (NASDAQ: RZLV) Receives Court Approval for Capital Reduction Supporting Up to $300 Million Share Repurchase Program

October 6, 2026 — Rezolve Ai (NASDAQ: RZLV) received Court approval for its proposed capital reduction, an important step toward implementing its previously announced share repurchase program of up to $300 million. The approval follows shareholder approval of the capital reduction, with the company expecting to commence repurchases after remaining procedural requirements become effective, subject to market conditions, available capital, liquidity, capital allocation priorities and other relevant factors.


MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Expects Q3 Revenue to Reach Second-Highest Level in Company History, Prepares HEI Launch

October 6, 2026 — Beeline Holdings (NASDAQ: BLNE) provided a preliminary update on third-quarter 2026 performance, expecting revenue to reach the second-highest quarterly level in company history and the highest since 2021, while achieving its highest margins to date. Beeline also expects its net loss to decline from Q2, adjusted EBITDA loss to improve to its lowest level in five years and its quarter-end cash position to be at least 50% higher than at the end of Q2.


BillionDollarBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Shareholders Approve All Matters at Annual General and Special Meeting

October 5, 2026 — This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced that shareholders approved all matters submitted for a vote at its annual general and special meeting, including the election of six directors, amendments to the company Articles and amendments to its share-based compensation plan.


NHS England Unveils Rapid Test for Brain Tumors

October 5, 2026 — Surgeons can now identify a brain tumor’s genetic makeup before a patient even leaves the operating table, cutting what used to be an eight-week wait for diagnosis down to about two hours. The Brain Tumor Research Center of Excellence at the University of Nottingham built the tool, and the NHS has already begun putting it to use.